Seegene develops PCR test to detect Monkeypox Virus

Monkeypox Virus

Published on: PR Newswire SEOUL, South Korea, June 28, 2022 /PRNewswire/ — Seegene Inc. (KQ965390), South Korea’s leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus. The Novaplex™ MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed using the company’s AI-based automated test development system, known as SGDDS (Seegene Digitalized Development System), and technologies […]

Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary

Published on: PR Newswire SEOUL, South Korea, March 17, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Glen Hansen, Ph.D., D(ABMM), FCCM, as the Head of Scientific and Medical Affairs of its United States subsidiary, Seegene Technologies. In this role, Dr. Hansen will provide clinical input to the development process of new products and initiate product […]

Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business

Published on: PR Newswire SEOUL, South Korea, March 2, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced the appointment of Richard S. Creager, Ph.D., as the CEO of its United States subsidiary, Seegene Technologies. Dr. Creager brings decades of real-world in vitro diagnostics business and molecular diagnostics (MDx) experience to the role, in which he will execute business strategies […]

Seegene develops reagent detecting Covid-19 infection in 30 minutes

Published on Korea Biomedical Review Seegene, a multiplex molecular diagnostics company, said that it has developed a diagnostic reagent that can identify the Covid-19 infection in 30 minutes. Seegene’s new product, Allplex SARS-CoV-2 fast MDx Assay, has obtained the Conformity European In-Vitro Diagnostics (CE-IVD) marking. The company plans to release it to the market after […]

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

Novaplex SARS-CoV-2 Variant assay mutations coverage table includes mutations consistent with Omicron, Stealth Omicron, Alpha, Beta, Gamma and Delta variants

The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron and its Stealth version. Published on: PR Newswire Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant landscape. The Novaplex™ SARS-CoV-2 Variants VII assay addresses Omicron and […]

Omicron Variant: Letter to our customers

To Our Valued Seegene Customer, The World Health Organization has identified the Omicron variant (B.1.1.529) as the latest strain of the SARS-CoV-2 virus to be designated as a Variant of Concern. As the first cases are emerging in the US, Seegene confirms that the performance or quality of the Seegene EUA Allplex™ 2019-nCoV Assay is […]

Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant

Published on: PR Newswire The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube Seegene will support countries in need of diagnostics to help slow Omicron’s spread Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay is […]

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

Image shows Seegene's STARlet AIOS All in one solution for molecular testing for laboratories

Published on: PR Newswire Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in the Atlanta, GA, United States AIOS is the MDx system that integrates Seegene’s liquid handler and real-time PCR instruments. Seegene MDx system will efficiently access a wide array of Seegene’s syndromic assays. Seegene Inc. (KQ 096530), a […]